Boston Scientific Corp
(MIL:1BSX)
€
85.5
0 (0%)
Market Cap: 126.98 Bil
Enterprise Value: 135.61 Bil
PE Ratio: 74.26
PB Ratio: 6.39
GF Score: 56/100 Boston Scientific Corp at Bank of America Merrill Lynch Health Care Conference Transcript
May 15, 2019 / 03:00PM GMT
Robert Adam Hopkins
BofA Merrill Lynch, Research Division - MD of Equity Research
Good to go here. Thanks, everybody, for coming out early. Las Vegas time anyway. I'm Bob Hopkins from BofA, and I want to say thank you very much to the Boston Scientific team for being here this morning. This is a fireside chat format. We have Dan Brennan, obviously, the company's Chief Financial Officer; and Susie Lisa, who runs Investor Relations. And just thrilled to have you guys here. Thank you.
Susan Vissers Lisa
Boston Scientific Corporation - VP of IR
Thanks, Bob.
Daniel J. Brennan
Boston Scientific Corporation - Executive VP & CFO
Pleasure to be here. Thanks for the invite.
Robert Adam Hopkins;Daniel J. Brennan
BofA Merrill Lynch, Research Division - MD of Equity Research;Boston Scientific
Dan, I don't know if there's a quick opening kind of message you want to deliver, or we'll just hop right into Q&A. Either way is fine with me.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot